Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection

ABSTRACTThe H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared t...

Full description

Bibliographic Details
Main Authors: Fei-Fei Xiong, Xue-Ying Liu, Fei-Xia Gao, Jian Luo, Peng Duan, Wen-Song Tan, Ze Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2019.1708214
_version_ 1797265823638749184
author Fei-Fei Xiong
Xue-Ying Liu
Fei-Xia Gao
Jian Luo
Peng Duan
Wen-Song Tan
Ze Chen
author_facet Fei-Fei Xiong
Xue-Ying Liu
Fei-Xia Gao
Jian Luo
Peng Duan
Wen-Song Tan
Ze Chen
author_sort Fei-Fei Xiong
collection DOAJ
description ABSTRACTThe H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared their protective effects against H7N9 influenza virus. The epitope mapping from escape mutants showed that all the seven mAbs could bind to the head region of the N9 NA close to the enzyme activity sites, and four key sites of N9 NA were reported for the first time. The mAbs D3 and 7H2 could simultaneously inhibit the cleavage of the sialic acid of fetuin protein with large molecular weight and NA-XTD with small molecule weight in the NA inhibition experiment, prevent the formation of virus plaque at a low concentration, and effectively protect the mice from the challenge of the lethal dose of H7N9 virus.
first_indexed 2024-03-07T17:24:19Z
format Article
id doaj.art-b6967c4e02894ecb8493d536d2b55c4c
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-04-25T00:50:55Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-b6967c4e02894ecb8493d536d2b55c4c2024-03-11T16:04:25ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-0191788710.1080/22221751.2019.1708214Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infectionFei-Fei Xiong0Xue-Ying Liu1Fei-Xia Gao2Jian Luo3Peng Duan4Wen-Song Tan5Ze Chen6Shanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaEast China University of Science and Technology, Shanghai, People’s Republic of ChinaShanghai Institute of Biological Products, Shanghai, People’s Republic of ChinaABSTRACTThe H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared their protective effects against H7N9 influenza virus. The epitope mapping from escape mutants showed that all the seven mAbs could bind to the head region of the N9 NA close to the enzyme activity sites, and four key sites of N9 NA were reported for the first time. The mAbs D3 and 7H2 could simultaneously inhibit the cleavage of the sialic acid of fetuin protein with large molecular weight and NA-XTD with small molecule weight in the NA inhibition experiment, prevent the formation of virus plaque at a low concentration, and effectively protect the mice from the challenge of the lethal dose of H7N9 virus.https://www.tandfonline.com/doi/10.1080/22221751.2019.1708214H7N9 influenza virusneuraminidasemonoclonal antibodiesprotectionNA epitope
spellingShingle Fei-Fei Xiong
Xue-Ying Liu
Fei-Xia Gao
Jian Luo
Peng Duan
Wen-Song Tan
Ze Chen
Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
Emerging Microbes and Infections
H7N9 influenza virus
neuraminidase
monoclonal antibodies
protection
NA epitope
title Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
title_full Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
title_fullStr Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
title_full_unstemmed Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
title_short Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
title_sort protective efficacy of anti neuraminidase monoclonal antibodies against h7n9 influenza virus infection
topic H7N9 influenza virus
neuraminidase
monoclonal antibodies
protection
NA epitope
url https://www.tandfonline.com/doi/10.1080/22221751.2019.1708214
work_keys_str_mv AT feifeixiong protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT xueyingliu protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT feixiagao protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT jianluo protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT pengduan protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT wensongtan protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection
AT zechen protectiveefficacyofantineuraminidasemonoclonalantibodiesagainsth7n9influenzavirusinfection